Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| HELVETIA BALOISE | 3 | 3 | -2,19 % | ||
| GALDERMA GROUP | 1 | 2 | +2,52 % | ||
| CLARIANT | - | 14 | -0,90 % | ||
| SUNRISE COMMUNICATIONS | - | 14 | -1,27 % | ||
| STRAUMANN | - | 10 | +0,60 % | ||
| SONOVA | - | 9 | -0,64 % | ||
| SGS | - | 6 | -0,47 % | ||
| GEORG FISCHER | - | 5 | +1,30 % | ||
| AVOLTA | - | 5 | -0,09 % | ||
| LINDT & SPRUENGLI | - | 3 | -0,55 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13:22 | Dennis Giavina ist der neue CTO von Helvetia Baloise | 3 | Inside IT | ||
| 12:58 | F. Hoffmann-La Roche Ltd: CHMP recommends EU approval of Roche's Ocrevus for children and adolescents with relapsing multiple sclerosis | 989 | GlobeNewswire (Europe) | Ocrevus addresses a critical need in paediatric neurology as the first high- efficacy anti-CD20 treatment option for people with MS as young as 10 years old In the Phase III OPERETTA 2 study, Ocrevus... ► Artikel lesen | |
| 12:30 | mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide | 189 | PR Newswire | mAbxience and Sandoz have entered into a collaboration agreement combining mAbxience's development and manufacturing expertise with Sandoz's global commercial capabilities for a proposed emicizumab... ► Artikel lesen | |
| 12:11 | Helvetia Baloise besetzt neue CTTO-Position mit Sandra Hürlimann | 3 | Swiss IT Reseller | ||
| 11:51 | Alliance Witan - Stock Spotlight: Galderma | 2 | QuotedData | ||
| 11:10 | Mehr Vielfalt gewünscht: Roche setzt auf 300.000 bispezifische Kombinationen | 7 | transkript.de | ||
| 10:46 | Roche agrees $1bn deal with Dualitas for bispecific antibody research | 13 | Pharmaceutical Technology | ||
| 08:18 | Sandoz Partners With MAbxience On Emicizumab Biosimilar; Pipeline Reaches 40 Assets | 299 | AFX News | WASHINGTON (dpa-AFX) - Sandoz Group AG (SDZ.SW, SDZNY), a pharmaceutical company focused on affordable medicines, on Friday announced a collaboration with mAbxience for a proposed emicizumab... ► Artikel lesen | |
| 08:17 | Sandoz schliesst Partnerschaft mit mAbxience für Hemlibra-Biosimilar von Roche | 16 | cash | ||
| 07:21 | Sandoz Group AG: Sandoz announces collaboration with mAbxience to expand patient access to life-enhancing biosimilar medicines | 353 | EQS Group (EN) | Sandoz Group AG
/ Key word(s): Agreement
Sandoz announces collaboration with mAbxience to expand patient access to life-enhancing biosimilar medicines 18.09.2026 / 07:15 CET/CEST
MEDIA... ► Artikel lesen | |
| 07:03 | Adhoc: Sandoz Group AG: Sandoz receives regulatory approval for generic semaglutide in Canada, paving way to expand patient access to key GLP-1 medicine | 600 | EQS Group (EN) | Sandoz Group AG / Key word(s): Regulatory Approval
Sandoz receives regulatory approval for generic semaglutide in Canada, paving way to expand patient access to key GLP-1 medicine 18-Sep-2026... ► Artikel lesen | |
| Do | F. Hoffmann-La Roche Ltd: Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases | 674 | GlobeNewswire (Europe) | The center will be a hub for Roche and Genentech, bringing together expertise in Cardiovascular, Renal and Metabolism, as well as for data science and AI specialists to drive innovation in drug discovery... ► Artikel lesen | |
| Do | Roche's Lunsumio delivers positive confirmatory trial readout in follicular lymphoma | 6 | FiercePharma | ||
| Do | RHHBY's Lunsumio Combo Meets Goal in 2L Follicular Lymphoma Study | 4 | Zacks | ||
| Do | 'People like the sincerity of it': comedian Damon Wayans on humor, relatability and DME awareness in Genentech campaign | 5 | FiercePharma | ||
| Do | Helvetia Baloise: Sandra Hürlimann wird Chief Technology & Transformation Officer (CTTO) | 4 | investrends.ch | ||
| Do | Roche signs $1B deal with Dualitas to pair up on big bispecific screening drive | 12 | FierceBiotech | ||
| Do | Roche and Dualitas Therapeutics announce research collaboration worth up to $1bn | 4 | PMLiVE | ||
| Do | Helvetia Baloise drückt bei der Integration aufs Tempo | 2 | finews.ch | ||
| Do | Roche succeeds in late-stage study for Lunsumio regimen in follicular lymphoma | 4 | Seeking Alpha |
1 2 3 4 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.